These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 12918692)

  • 1. Comparison of proteome map between sera of patients with Behçet's disease and controls.
    Lee KH; Kim H; Lee S; Bang D
    Adv Exp Med Biol; 2003; 528():213-5. PubMed ID: 12918692
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of leptin level and Ob gene polymorphism in patients with Behcet's disease.
    Okudan N; Acar H; Gökbel H; Mevlitoğlu I; Sari F
    Arch Dermatol Res; 2006 Aug; 298(3):127-30. PubMed ID: 16786343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MICA transmembrane region polymorphism and HLA B51 in Tunisian Behçet's disease patients.
    Ben Ahmed M; Houman H; Abdelhak S; Ben Ghorbel I; Miled M; Dellagi K; Louzir H
    Adv Exp Med Biol; 2003; 528():225-8. PubMed ID: 12918695
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombomodulin levels in Behçet's disease with and without the factor V Leiden mutation.
    Gürgey A; Gurler A; Oner AF; Mesci L; Kirazli S
    Clin Rheumatol; 1998; 17(3):186-8. PubMed ID: 9694049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behçet's disease.
    Chamberlain MA
    Br Med J; 1978 Nov; 2(6148):1369-70. PubMed ID: 719402
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
    Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
    Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of autoantibodies against oral and vascular-related cell lines in the sera of patients with Behcet's disease.
    Ataollahi M; Gharesi-Fard B; Aflaki E
    Clin Lab; 2013; 59(11-12):1271-6. PubMed ID: 24409661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Von Willebrand factor antigen levels in Behçet disease.
    Beyan E; Sadikoğlu B; Ertuğrul E; Beyan C
    Am J Hematol; 2005 May; 79(1):70-2. PubMed ID: 15849757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behçet's disease sera containing antiendothelial cell antibodies promote adhesion of T lymphocytes to cultured human dermal microvascular endothelial cells.
    Lee KH; Chung HS; Bang D; Lee S
    Yonsei Med J; 1999 Apr; 40(2):152-8. PubMed ID: 10333719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
    Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
    Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-B51 frequency in Iranian patients with Behçet's disease.
    Shahram F; Davatchi F; Nadji A; Jamshidi A; Bahar K; Akbarian M; Chams C
    Adv Exp Med Biol; 2003; 528():229-30. PubMed ID: 12918696
    [No Abstract]   [Full Text] [Related]  

  • 12. Familial Behçet's disease.
    Akpolat T; Koç Y; Yeniay I; Akpek G; Güllü I; Kansu E; Kiraz S; Ersoy F; Batman F; Kansu T
    Eur J Med; 1992 Nov; 1(7):391-5. PubMed ID: 1341477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid-soluble protein in Behçet's disease.
    Shimakawa M; Kogure M
    Am J Ophthalmol; 1986 Aug; 102(2):281-2. PubMed ID: 3790207
    [No Abstract]   [Full Text] [Related]  

  • 14. Strong association of MIC-A*009 of extracellular domains and MIC-A*A6 of transmembrane domain in Korean patients with Behçet's disease.
    Mok J; Bang D; Lee ES; Lee S; Park K
    Adv Exp Med Biol; 2003; 528():221-4. PubMed ID: 12918694
    [No Abstract]   [Full Text] [Related]  

  • 15. Spontaneous platelet aggregation in patients with Behçet's disease by using laser-light scattering aggregometer.
    Nakano H; Oka H; Matsuda T; Ooka S; Suzuki N; Hayashi J; Ishida S; Suzuki T; Hirota K; Ozaki S
    Adv Exp Med Biol; 2003; 528():437-41. PubMed ID: 12918740
    [No Abstract]   [Full Text] [Related]  

  • 16. A unique case of thrombosis in Behçet's disease with methylene tetrahydrofolate reductase homozygous polymorphism and raised homocysteine levels.
    Vasudevan B; Verma R; Pragasam V; Malik A; Venugopal R; Gopal M
    Indian J Dermatol Venereol Leprol; 2013; 79(4):531-3. PubMed ID: 23760328
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of prothrombotic risk in patients with Behçet's disease should include homocysteine plasma levels.
    Danese S; Papa A; Gasbarrini G; Gasbarrini A
    J Rheumatol; 2001 Dec; 28(12):2764-5. PubMed ID: 11764237
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum leptin levels in patients with ocular and nonocular Behçet's disease.
    Yalçindağ FN; Kisa U; Batioğlu F; Yalçindağ A; Ozdemir O; Cağlayan O
    Mediators Inflamm; 2007; 2007():31986. PubMed ID: 17641728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low serum mannose-binding lectin levels in Behçet's disease.
    Inanc N; Birtas E; Yavuz S; Ergun T; Direskeneli H
    Adv Exp Med Biol; 2003; 528():287-9. PubMed ID: 12918709
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of homocysteine, neopterin and nitric oxide levels in Behçet's disease.
    Ozkan Y; Yardim-Akaydin S; Sepici A; Engin B; Sepici V; Simşek B
    Clin Chem Lab Med; 2007; 45(1):73-7. PubMed ID: 17243919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.